Abbott Laboratories ROE 2006-2019 | ABT

Current and historical return on equity (ROE) values for Abbott Laboratories (ABT) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Abbott Laboratories ROE for the three months ending March 31, 2019 was 17.39%.
Abbott Laboratories ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-03-31 $2.62B $31.13B 8.49%
2018-12-31 $2.37B $30.72B 7.64%
2018-09-30 $0.89B $30.90B 2.85%
2018-06-30 $0.93B $30.77B 2.95%
2018-03-31 $0.48B $31.60B 1.50%
2017-12-31 $0.48B $31.10B 1.51%
2017-09-30 $2.10B $32.22B 7.23%
2017-06-30 $1.17B $31.79B 4.46%
2017-03-31 $1.50B $31.55B 6.40%
2016-12-31 $1.40B $20.72B 6.73%
2016-09-30 $1.37B $20.90B 6.53%
2016-06-30 $2.28B $20.80B 10.82%
2016-03-31 $2.45B $20.84B 11.31%
2015-12-31 $4.42B $21.33B 20.18%
2015-09-30 $4.56B $21.22B 20.74%
2015-06-30 $4.52B $23.13B 20.14%
2015-03-31 $4.20B $21.99B 18.60%
2014-12-31 $2.28B $21.64B 9.95%
2014-09-30 $1.97B $22.99B 8.25%
2014-06-30 $2.40B $23.70B 9.96%
2014-03-31 $2.41B $23.49B 10.14%
2013-12-31 $2.58B $25.27B 10.94%
2013-09-30 $3.04B $23.79B 12.70%
2013-06-30 $4.02B $22.43B 16.22%
2013-03-31 $5.27B $22.68B 20.82%
2012-12-31 $5.96B $26.81B 22.93%
2012-09-30 $6.53B $27.10B 25.67%
2012-06-30 $4.89B $24.57B 19.69%
2012-03-31 $5.11B $25.54B 20.18%
2011-12-31 $4.73B $24.53B 18.84%
2011-09-30 $4.55B $24.69B 18.45%
2011-06-30 $5.14B $26.47B 21.54%
2011-03-31 $4.49B $24.72B 20.18%
2010-12-31 $4.63B $22.77B 21.71%
2010-09-30 $4.73B $21.48B 22.06%
2010-06-30 $5.31B $20.00B 24.84%
2010-03-31 $5.31B $21.01B 24.84%
2009-12-31 $5.75B $23.19B 27.87%
2009-09-30 $5.74B $21.38B 29.91%
2009-06-30 $5.35B $19.92B 28.61%
2009-03-31 $5.38B $17.98B 29.17%
2008-12-31 $4.88B $17.52B 26.45%
2008-09-30 $4.55B $19.35B 24.55%
2008-06-30 $4.18B $18.96B 23.76%
2008-03-31 $3.85B $17.98B 23.05%
2007-12-31 $3.61B $17.82B 22.87%
2007-09-30 $1.93B $15.61B 13.00%
2007-06-30 $1.93B $15.33B 12.99%
2007-03-31 $1.55B $14.32B 10.47%
2006-12-31 $1.72B $14.05B 11.58%
2006-09-30 $3.17B $15.63B 21.24%
2006-06-30 $3.13B $15.19B 21.50%
2006-03-31 $3.40B $14.44B 23.64%
2005-12-31 $3.37B $14.42B 23.56%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $151.296B $30.578B
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $135.350B 19.33
Stryker (SYK) United States $77.587B 27.69
Boston Scientific (BSX) United States $58.741B 28.16
Baxter (BAX) United States $42.165B 26.58
EssilorLuxottica Societe Anonyme (ESLOY) France $28.527B 0.00
Coloplast (CLPBY) Denmark $25.661B 40.97
Lonza Group Ag (LZAGY) Switzerland $25.304B 0.00
Zimmer Biomet Holdings (ZBH) United States $25.194B 16.19
Terumo (TRUMY) Japan $22.193B 25.52
Smith & Nephew SNATS (SNN) United Kingdom $19.113B 0.00
ResMed (RMD) United States $17.749B 33.91
Canopy Growth (CGC) Canada $12.652B 0.00
Sunny Optical Technology (SNPTF) China $12.175B 0.00
Bio-Rad Laboratories (BIO) United States $9.194B 48.74
Aurora Cannabis (ACB) Canada $7.514B 74.10
William Demant Holdings (WILYY) Denmark $7.411B 0.00
Insulet (PODD) United States $7.236B 527.17
Hill-Rom Holdings (HRC) United States $7.121B 21.59
Perrigo (PRGO) Ireland $6.850B 11.58
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.254B 51.05
ICU Medical (ICUI) United States $5.122B 30.57
GW Pharmaceuticals (GWPH) United Kingdom $4.916B 0.00
Neogen (NEOG) United States $3.373B 54.85
NuVasive (NUVA) United States $2.987B 24.39
Hutchison China MediTech (HCM) China $2.906B 0.00
Agios Pharmaceuticals (AGIO) United States $2.848B 0.00
National Vision Holdings (EYE) United States $2.479B 52.82
Quidel (QDEL) United States $2.261B 23.46
Aphria (APHA) $1.646B 0.00
Cardiovascular Systems (CSII) United States $1.530B 878.80
Phibro Animal Health (PAHC) United States $1.212B 18.16
AtriCure (ATRC) United States $1.196B 0.00
VAREX IMAGING (VREX) United States $1.177B 24.98
NanoString Technologies (NSTG) United States $1.065B 0.00
Lantheus Holdings (LNTH) United States $1.052B 27.95
PetIQ (PETQ) United States $1.008B 24.49
Quanterix (QTRX) United States $0.783B 0.00
Cerus (CERS) United States $0.769B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.758B 21.26
Omeros (OMER) United States $0.758B 0.00
MacroGenics (MGNX) United States $0.740B 0.00
TG Therapeutics (TGTX) United States $0.686B 0.00
LeMaitre Vascular (LMAT) United States $0.591B 28.62
Surmodics (SRDX) United States $0.533B 77.45
OraSure Technologies (OSUR) United States $0.522B 24.06
Meridian Bioscience (VIVO) United States $0.489B 14.96
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.398B 0.00
Vapotherm (VAPO) United States $0.337B 0.00
Utah Medical Products (UTMD) United States $0.325B 22.51
BioLife Solutions (BLFS) United States $0.313B 97.88
Zynex (ZYXI) United States $0.242B 24.90
Cytosorbents (CTSO) United States $0.234B 0.00
Bovie Medical (APYX) United States $0.224B 0.00
Chimerix (CMRX) United States $0.184B 0.00
Owens & Minor (OMI) United States $0.178B 3.77
United Health Products (UEEC) United States $0.175B 0.00
Rockwell Medical (RMTI) United States $0.168B 0.00
Female Health (VERU) United States $0.143B 0.00
Fonar (FONR) United States $0.141B 7.40
Chembio Diagnostics (CEMI) United States $0.100B 0.00
United-Guardian (UG) United States $0.091B 19.97
InfuSystems Holdings (INFU) United States $0.088B 0.00
Surface Oncology (SURF) United States $0.076B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.066B 0.00
Trinity Biotech (TRIB) Ireland $0.057B 19.58
MRI INTERVENTNS (MRIC) United States $0.053B 0.00